Skip to content

Nurse attitudes, clinic experience, key to improving care and retention in ARV programmes

Accelerated hepatitis B vaccine schedule boosts completion rates in IDUs

FDA will give fast-track to tenofovir gel approval

Sensitive test finds high rate of transmitted drug-resistant HIV in UK

Darunavir working well for highly treatment-experienced patients in Switzerland

New model shows future impact of circumcision on Africa's HIV epidemic probably underestimated

Fixed dose ARV for children: half-dose to limit nevirapine rash is safe in first 2 weeks

Drug safety bodies issue warning on heart rhythm risks with saquinavir (Invirase)

More HIV-negative men are having unprotected sex in primary relationships, but not all of them know their partner’s status